1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide, 95.0%, 250mg

[S(R)]-N-[(S)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide, 95%, 50mg

2-(3-Bromo-phenyl)-1H-imidazole, 95.0%, 250mg

(2R,4'R,8a'R)-1-tert-butyl 4'-methyl 6'-oxohexahydrospiro[pyrrolidine-2,7'-pyrrolo[2,1-b][1,3]thiazine]-1,4'-dicarboxylate, 98%, 25mg

4-Methoxy-3-(methoxymethoxy)benzaldehyde>96.0%(GC)1g

4-bromo-3-fluoro-3'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

6-Bromo-2-chloroimidazo[1,2-a]pyridine, 95.0%, 250mg

tert-Butyl ethyl(2-(ethylamino)ethyl)carbamate, 98%, 100mg

1-(2-furylmethyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid, 95.0%, 100mg

(2S)-2-Amino-2-phenylethanamide, 95.0%, 100g

1-Bromo-4-(trans-4-propylcyclohexyl)benzene, 97%, 5g

Magnetic bar ejector ROTILABO®, 350 mm, 1 piece

2-[2-(2-Azidoethoxy)ethoxy]ethanol, 98.0%, 25g